Atkinson Edward Morrow III (CIK 1914164) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-26). Recent activity: Sell VRTX (1,627 shares), Sell VRTX (668 shares), Buy VRTX (4,962 shares), Sell VRTX (1,530 shares), Sell VRTX (2,031 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 1,627 | $789,274 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 668 | $324,882 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Buy | 4,962 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 1,530 | $740,138 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 2,031 | $994,093 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 817 | $386,997 |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 1,903 | $928,207 |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 872 | $408,454 |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 1,751 | $806,213 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Buy | 3,934 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Buy | 3,883 | $0 |
| 2025-11-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Technical Ops. Off. | Sell | 2,500 | $1.1M |
Source: SEC Form 4 filings · as of 2026-02-26